Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis Full Text
Brain, 05/23/2012
Elliott C et al. – The observation underlines the mechanistic heterogeneity of multiple sclerosis and provides a rational explanation why some patients benefit from antibody depleting treatments.



